Abdelrahman Tageldin
Durban, ZN, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dual-targeting sepsis-associated inflammation and infection using linoleic acid-based lipid-polymer hybrid nanoparticles.
Journal: Journal of materials chemistry. B
Published: May 14, 2026
Novel lipid and ascorbyl stearate biomimetic vancomycin-loaded nanostructured lipid carrier therapy for bacterial infections and sepsis.
Journal: RSC advances
Published: February 16, 2026
Uncovering potential targets for MRSA infection treatment: a nanomedicine perspective.
Journal: Expert opinion on therapeutic targets
Published: February 10, 2026
A novel biomimetic and redox-responsive hybrid lipid polymer nanoparticle for targeting sepsis microenvironment and modulating inflammation.
Journal: International journal of pharmaceutics
Published: October 16, 2025
Potential of nanocarrier-mediated delivery of vancomycin for MRSA infections.
Journal: Expert opinion on drug delivery
Published: February 14, 2025
Hyaluronic acid-silybin conjugate for the preparation of multifunctional, biomimetic, vancomycin-loaded self-assembled polymersomes against bacterial sepsis.
Journal: International journal of biological macromolecules
Published: September 13, 2024
Engineered extracellular vesicles coated with an antimicrobial peptide for advanced control of bacterial sepsis.
Journal: Journal of extracellular biology
Published: April 10, 2024
Engineering dynamic covalent bond-based nanosystems for delivery of antimicrobials against bacterial infections.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 27, 2024
Novel peptide and hyaluronic acid coated biomimetic liposomes for targeting bacterial infections and sepsis.
Journal: International journal of pharmaceutics
Published: December 07, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026